These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Preparation of the sequence 16-29 of the glucagons]. Wünsch E; Wendlberger G Chem Ber; 1967; 100(3):820-7. PubMed ID: 5594477 [No Abstract] [Full Text] [Related]
6. [On the synthesis of glucagons. Preparation of the sequence 22-29 (new way)]. Wünsch E; Drees F Chem Ber; 1967; 100(3):816-9. PubMed ID: 5594476 [No Abstract] [Full Text] [Related]
7. Synthesis of the nonacosapeptide corresponding to mammalian glucagon. Fujino M; Wakimasu M; Shinagawa S; Kitada C; Yajima H Chem Pharm Bull (Tokyo); 1978 Feb; 26(2):539-48. PubMed ID: 639175 [No Abstract] [Full Text] [Related]
8. [Total synthesis of the pancreatic hormone glucagon]. Wünsch E Z Naturforsch B; 1967 Dec; 22(12):1269-76. PubMed ID: 4384723 [No Abstract] [Full Text] [Related]
11. [Insulin, glucagon, somatotropic hormone]. Dérot M; Pignard P Journ Annu Diabetol Hotel Dieu; 1972; 13(0):7-11. PubMed ID: 4679588 [No Abstract] [Full Text] [Related]
12. Preparation and properties of glucagon analogs prepared by semi-synthesis from CNBr-glucagon. Wright DE; Hruby VJ; Rodbell M Biochim Biophys Acta; 1980 Aug; 631(1):49-58. PubMed ID: 6249392 [TBL] [Abstract][Full Text] [Related]
13. Selectively blocked and des-histidine-glucagons: preparation and effects on hepatic adenylate cyclase activity. Lande S; Gorman R; Bitensky M Endocrinology; 1972 Mar; 90(3):597-604. PubMed ID: 4333141 [No Abstract] [Full Text] [Related]
14. Recent trends in the synthesis of linear peptides. Kapoor A J Pharm Sci; 1970 Jan; 59(1):1-27. PubMed ID: 4903955 [No Abstract] [Full Text] [Related]
15. [25-oxindolylalanine]glucagon and [27-methionine sulfoxide]glucagon: preparation, purification, and characterization. Coolican SA; Jones BN; England RD; Flanders KC; Condit JD; Gurd RS Biochemistry; 1982 Sep; 21(20):4974-81. PubMed ID: 7138842 [No Abstract] [Full Text] [Related]
16. [Synthesis of peptides by aqueous phase method. 4]. Kato T; Aoyagi H; Waki M; Mitsuyasu N; Izumiya N Tanpakushitsu Kakusan Koso; 1971 Apr; 16(4):293-303. PubMed ID: 4929104 [No Abstract] [Full Text] [Related]
17. Differential acid stabilities of citraconylated amino groups of glucagon. Preparation of N alpha-citraconyl glucagon and evaluation of its biological properties. Liepnieks JJ; Epand RM Biochim Biophys Acta; 1982 Oct; 707(2):171-7. PubMed ID: 6291617 [TBL] [Abstract][Full Text] [Related]
18. Biological activities of glucagon-like peptide-1 analogues in vitro and in vivo. Xiao Q; Giguere J; Parisien M; Jeng W; St-Pierre SA; Brubaker PL; Wheeler MB Biochemistry; 2001 Mar; 40(9):2860-9. PubMed ID: 11258897 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of vasoactive intestinal peptide and related peptides. Bodanszky M Ann N Y Acad Sci; 1988; 527():20-8. PubMed ID: 3291693 [No Abstract] [Full Text] [Related]
20. Potentiation of glucose-induced insulin release in islets by desHis1[Glu9]glucagon amide. Kofod H; Unson CG; Merrifield RB Int J Pept Protein Res; 1988 Dec; 32(6):436-40. PubMed ID: 3073146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]